[Pe-021] English Poster Session 021

[Pe-021-4] The design of CIELO: A phase 3 trial of satralizumab in patients with autoimmune encephalitis (AE)

Hideto Nakajima¹, Hesham Abboud², Sarosh R. Irani³, Soon-tae Lee⁴, Amanda Piquet⁵, Sean J. Pittock⁶, Ann E. Yeh⁷, James Overell⁸, Sharmila Rajan⁹, Muna El-khairi¹⁰, Jeffrey M. Gelfand¹¹ (1.Nihon University, Neurology, Japan, 2.UH Cleveland Medical Center, USA, 3.NDCN, Oxford University, UK, 4.Seoul National University Hospital, Korea, 5.University of Colorado, USA, 6.Mayo Clinic, USA, 7.SickKids, University of Toronto, Canada, 8.F. Hoffmann-La Roche Ltd., Switzerland, 9.Genentech, Inc., USA, 10.Roche Products Ltd., UK, 11.UCSF, USA)